Zebrafish Protein & Antibody Core

斑马鱼蛋白

基本信息

  • 批准号:
    7483030
  • 负责人:
  • 金额:
    $ 27.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-01 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Zebrafish Protein & Antibody Core will take the first formal step in creating a national resource for the production of zebrafish proteins and their respective antibodies for use by the zebrafish research community. Effort will center on three efforts: 1) production of zebrafish proteins and protein fragments; 2) production of antibody fragments; and 3) the fabrication of arrayed proteins and affinity reagents. Zebrafish proteins targeted for expression would include transcription factors, enzymes, cytoskeletal proteins, cell signaling proteins, growth factors, ectodomains of receptors, etc. Wherever possible, full-length versions of the proteins would be expressed, but due to the difficulty of working with certain protein classes (e.g., membrane proteins, multi-domain proteins), their expression would be limited to soluble domains. Expression would be achieved primarily in E. coli, with insect cell systems used for high priority targets. For the first year, a variety of different protein classes would be targeted so that we may develop protocols relevant to a wide range of proteins; we would aim for the expression of 100 proteins, and the generation of antibodies to 50 targets. During the second year, we would ramp up the production scale of targets and antibodies by 50%, and phase in proteins nominated by the community at large. It is anticipated that the number of user requests would double during the third year, for a total of 200 proteins and 100 antibodies. In addition, we would fabricate arrays of proteins and antibodies for distribution during the third year. To oversee this pilot project, there will be a scientific advisory committee composed of zebrafish scientists, and a technical advisory committee composed of biotechnologists. We propose a sharing plan consisting of a website containing publicly accessible data, presentations at scientific meetings, and distribution of requested reagents and protocols.
描述(由申请人提供):斑马鱼蛋白质和抗体核心将采取第一个正式步骤,为斑马鱼蛋白质及其各自的抗体的生产创建国家资源,供斑马鱼研究界使用。研究工作将集中在三个方面:1)生产斑马鱼蛋白质和蛋白质片段; 2)生产抗体片段; 3)制造阵列蛋白质和亲和试剂。靶向表达的斑马鱼蛋白质包括转录因子、酶、细胞骨架蛋白、细胞信号传导蛋白、生长因子、受体的胞外域等。只要可能,将表达蛋白质的全长形式,但由于难以与某些蛋白质类别(例如,膜蛋白、多结构域蛋白),它们的表达将限于可溶性结构域。主要在E.大肠杆菌,昆虫细胞系统用于高优先级目标。第一年,我们将针对各种不同的蛋白质类别,以便我们可以开发与各种蛋白质相关的方案;我们的目标是表达100种蛋白质,并产生针对50种靶标的抗体。在第二年,我们将把目标和抗体的生产规模提高50%,并逐步采用社区提名的蛋白质。预计在第三年期间,用户请求的数量将翻一番,总共需要200种蛋白质和100种抗体。此外,我们将在第三年制造蛋白质和抗体的阵列。为了监督这个试点项目,将有一个由斑马鱼科学家组成的科学咨询委员会和一个由生物技术专家组成的技术咨询委员会。我们提出了一个共享计划,包括一个网站,其中包含公开访问的数据,在科学会议上的演示文稿,并要求的试剂和协议的分布。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIAN KENNETH KAY其他文献

BRIAN KENNETH KAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIAN KENNETH KAY', 18)}}的其他基金

Generating fast-on rate reagents for lateral flow assays to detect HCV
生成用于侧向层析检测 HCV 的快速试剂
  • 批准号:
    10697630
  • 财政年份:
    2023
  • 资助金额:
    $ 27.74万
  • 项目类别:
High-throughput profiling of proteases with phage and arrays
使用噬菌体和阵列对蛋白酶进行高通量分析
  • 批准号:
    10602245
  • 财政年份:
    2023
  • 资助金额:
    $ 27.74万
  • 项目类别:
Building a pipeline to generate affinity reagents to phosphothreonine epitopes
建立生产磷酸苏氨酸表位亲和试剂的管道
  • 批准号:
    10481540
  • 财政年份:
    2022
  • 资助金额:
    $ 27.74万
  • 项目类别:
Array Based Affinity Selection
基于阵列的亲和力选择
  • 批准号:
    10163532
  • 财政年份:
    2019
  • 资助金额:
    $ 27.74万
  • 项目类别:
Enzyme-delivery scaffold technology for targeted cancer killing.
用于靶向杀死癌症的酶递送支架技术。
  • 批准号:
    8311639
  • 财政年份:
    2011
  • 资助金额:
    $ 27.74万
  • 项目类别:
Technology Development for Recombinant Affinity Reagents
重组亲和试剂技术开发
  • 批准号:
    8335435
  • 财政年份:
    2011
  • 资助金额:
    $ 27.74万
  • 项目类别:
Technology Development for Recombinant Affinity Reagents
重组亲和试剂技术开发
  • 批准号:
    8218358
  • 财政年份:
    2011
  • 资助金额:
    $ 27.74万
  • 项目类别:
Enzyme-delivery scaffold technology for targeted cancer killing.
用于靶向杀死癌症的酶递送支架技术。
  • 批准号:
    8518269
  • 财政年份:
    2011
  • 资助金额:
    $ 27.74万
  • 项目类别:
Enzyme-delivery scaffold technology for targeted cancer killing.
用于靶向杀死癌症的酶递送支架技术。
  • 批准号:
    8034009
  • 财政年份:
    2011
  • 资助金额:
    $ 27.74万
  • 项目类别:
Phage Display Investigations of TDP-43
TDP-43 的噬菌体展示研究
  • 批准号:
    7941728
  • 财政年份:
    2009
  • 资助金额:
    $ 27.74万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 27.74万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 27.74万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 27.74万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 27.74万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 27.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 27.74万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 27.74万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 27.74万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 27.74万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 27.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了